Molina Healthcare, Inc. logo

Molina Healthcare, Inc.

MOH

NYSEHealthcareMedical - Healthcare Plans

Regular session

$199.06

−$1.235 · -0.62%

Aug 24, 2:12 PM ET

MOH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

51

Fair Value

Momentum

71

Gaining

Sentiment

61

Bullish

Risk resilience

70

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.

Industry
Medical - Healthcare Plans
Sector
Healthcare
Headquarters
US
CEO
Joseph Michael Zubretsky
Listed since
Jul 2, 2003
Employees
19,000

Market position

Day range

Current $199.06

52-week range

Current $199.06

Open
$200.68
Previous close
$200.29
Volume
216.67K
0.19× average
Average volume
1.17M
Average daily volume
Market cap
10.39B USD
Beta
0.75
Market reference 1
50-day average
$210.61
-5.49% below average
200-day average
$174.54
+14.05% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
8.52B USD
P/E (TTM)
1,244.09×
P/B (TTM)
2.45×
P/S (TTM)
0.23×
EV / EBITDA
8.73×
Earnings yield
5.35%
Free cash flow yield
-7.22%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
34.56%
Operating margin
0.66%
Net margin
-0.02%
Return on equity
11.60%
Return on assets
3.03%
Return on invested capital
7.64%

Financial health

Debt / equity
0.95×
Current ratio
1.69×
Altman Z-score
4.07
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends14%9%5%-0%Gross margin, FY2021: 11.81%Gross margin, FY2022: 12.28%Gross margin, FY2023: 12.72%Gross margin, FY2024: 11.65%Gross margin, FY2025: 13.07%Operating margin, FY2021: 3.67%Operating margin, FY2022: 4.32%Operating margin, FY2023: 4.62%Operating margin, FY2024: 4.20%Operating margin, FY2025: 1.72%Net margin, FY2021: 2.37%Net margin, FY2022: 2.48%Net margin, FY2023: 3.20%Net margin, FY2024: 2.90%Net margin, FY2025: 1.04%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 11.81%. Gross margin FY2022 12.28%. Gross margin FY2023 12.72%. Gross margin FY2024 11.65%. Gross margin FY2025 13.07%. Operating margin FY2021 3.67%. Operating margin FY2022 4.32%. Operating margin FY2023 4.62%. Operating margin FY2024 4.20%. Operating margin FY2025 1.72%. Net margin FY2021 2.37%. Net margin FY2022 2.48%. Net margin FY2023 3.20%. Net margin FY2024 2.90%. Net margin FY2025 1.04%.

Income trends

Revenue

45.43B USD+11.75%

Operating income

781M USD-54.25%

Net income

472M USD-59.97%
Income trends across reported periods49.92B USD31.94B USD13.96B USD−4.02B USDRevenue, FY2021: 27.77B USDRevenue, FY2022: 31.97B USDRevenue, FY2023: 34.07B USDRevenue, FY2024: 40.65B USDRevenue, FY2025: 45.43B USDOperating income, FY2021: 1.02B USDOperating income, FY2022: 1.38B USDOperating income, FY2023: 1.57B USDOperating income, FY2024: 1.71B USDOperating income, FY2025: 781M USDNet income, FY2021: 659M USDNet income, FY2022: 792M USDNet income, FY2023: 1.09B USDNet income, FY2024: 1.18B USDNet income, FY2025: 472M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 27.77B USD. Revenue FY2022 31.97B USD. Revenue FY2023 34.07B USD. Revenue FY2024 40.65B USD. Revenue FY2025 45.43B USD. Operating income FY2021 1.02B USD. Operating income FY2022 1.38B USD. Operating income FY2023 1.57B USD. Operating income FY2024 1.71B USD. Operating income FY2025 781M USD. Net income FY2021 659M USD. Net income FY2022 792M USD. Net income FY2023 1.09B USD. Net income FY2024 1.18B USD. Net income FY2025 472M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue45.43B USD40.65B USD34.07B USD31.97B USD27.77B USD
Cost of goods sold39.49B USD35.91B USD29.74B USD28.05B USD24.49B USD
Gross profit5.94B USD4.74B USD4.33B USD3.93B USD3.28B USD
Selling, general, and administrative3.01B USD2.74B USD2.46B USD2.31B USD2.07B USD
Operating expenses5.16B USD3.03B USD2.76B USD2.55B USD2.26B USD
Interest expense192M USD118M USD109M USD110M USD120M USD
Depreciation and amortization195M USD186M USD171M USD176M USD131M USD
Operating income781M USD1.71B USD1.57B USD1.38B USD1.02B USD
Net income472M USD1.18B USD1.09B USD792M USD659M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
64%
7 beats, 4 misses, 0 met estimates
Average EPS surprise
-69.12%
11 comparable reports
Latest EPS result
1.51
Estimate 1.39 · Beat by 8.63%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates6.793.37-0.04-3.46Q1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 5.05, estimate 5.74, surprise -12.02%, Miss. Q2 2025, reported Apr 23, 2025: actual 6.08, estimate 5.97, surprise +1.84%, Beat. Q3 2025, reported Jul 23, 2025: actual 5.48, estimate 5.62, surprise -2.49%, Miss. Q4 2025, reported Oct 22, 2025: actual 1.84, estimate 3.97, surprise -53.65%, Miss. Q1 2026, reported Feb 5, 2026: actual -2.75, estimate 0.43, surprise -739.53%, Miss. Q2 2026, reported Apr 22, 2026: actual 2.35, estimate 1.9, surprise +23.68%, Beat. Q3 2026, reported Jul 22, 2026: actual 1.51, estimate 1.39, surprise +8.63%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 0.823, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates11.94B11.23B10.53B9.82BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 10.5B USD, estimate 10.28B USD, surprise +2.09%, Beat. Q2 2025, reported Apr 23, 2025: actual 11.15B USD, estimate 10.84B USD, surprise +2.79%, Beat. Q3 2025, reported Jul 23, 2025: actual 11.43B USD, estimate 10.95B USD, surprise +4.33%, Beat. Q4 2025, reported Oct 22, 2025: actual 11.48B USD, estimate 11.29B USD, surprise +1.68%, Beat. Q1 2026, reported Feb 5, 2026: actual 11.38B USD, estimate 10.88B USD, surprise +4.56%, Beat. Q2 2026, reported Apr 22, 2026: actual 10.8B USD, estimate 10.87B USD, surprise -0.72%, Miss. Q3 2026, reported Jul 22, 2026: actual 10.87B USD, estimate 10.83B USD, surprise +0.39%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 10.86B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$205.45

3.21% upside
Past 12 months12-month forecastHigh $286Average $205.45Low $129

Rating distribution

39 ratings
Strong buy00%
Buy1744%
Hold1641%
Sell615%
Strong sell00%

Recent analyst actions

12 institutions

MOH news

Corporate actions

Corporate action history

Stock split

Effective May 23, 2011

3:2

MOH peers

ETFs holding MOH

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research MOH

research.disclaimer